Characterization of liver lesions by real-time contrast-enhanced ultrasonography
Authors:
- Natascia CelliNCNatascia Celli
- Stefano GaianiSGStefano Gaiani
- Fabio PiscagliaFPFabio Piscaglia
- Gianni ZironiGZGianni Zironi
- Valeria CamaggiVCValeria Camaggi
- Simona LeoniSLSimona Leoni
- Roberto RighiniRRRoberto Righini
- Luigi BolondiLBLuigi Bolondi
- 1 January 2007
- journal article
- Published by Wolters Kluwer Health in European Journal of Gastroenterology & Hepatology
- Vol. 19 (1) , 3-14
Abstract
The aim of this study was to identify the most common patterns of various common liver lesions at real-time contrast-enhanced ultrasonography with second-generation contrast agents and their role in the differentiation of malignant from benign lesions. The enhancement pattern in the arterial phase and its modifications in subsequent portal and sinusoidal phases were separately evaluated in (i) 171 liver lesions detected at conventional ultrasonography in 125 noncirrhotic patients (87 metastases, six cholangiocellular carcinoma, 38 focal nodular hyperplasia, 30 hemangiomas, seven focal fatty sparing/changes, two hepatocellular adenomas and one hepatocellular carcinoma) and (ii) 75 lesions detected in 67 cirrhotic patients (66 hepatocellular carcinoma and nine dysplastic nodules). The final diagnosis was made by contrast-enhanced helical computed tomography and/or magnetic resonance imaging or by ultrasonography-guided biopsy when the diagnosis was equivocal at conventional imaging techniques (45 lesions). In noncirrhotic patients, the hypoechoic pattern in portal and sinusoidal phase (rapid washout) or the markedly hypoechoic or anechoic pattern in sinusoidal phase (marked late washout) showed a sensitivity, specificity and accuracy of 96.8, 100 and 98.2% for the diagnosis of malignancy. In cirrhotic patients, early arterial enhancement showed a sensitivity of 93.9% for the diagnosis of malignancy, with a specificity as low as 55.5% given the presence of arterial enhancement in 5/9 nodules resulted dysplastic at histological analysis. Real-time contrast-enhanced ultrasonography provides sensitive and specific criteria for the differential diagnosis between benign and malignant liver lesions, and in most cases it may replace more expensive and invasive imaging techniques.Keywords
This publication has 47 references indexed in Scilit:
- Improved Characterization of Liver Lesions with Liver-Phase Uptake of Liver-specific Microbubbles: Prospective Multicenter StudyRadiology, 2004
- Vascularity of liver tumours and recent advances in Doppler ultrasoundJournal of Hepatology, 2001
- Ultrasound contrast harmonic imaging of abdominal organsSeminars in Ultrasound, CT and MRI, 2001
- Assessment of Vascular Patterns of Small Liver Mass Lesions: Value and Limitation of The Different Doppler Ultrasound ModalitiesAmerican Journal of Gastroenterology, 2000
- Hepatocellular carcinoma: power Doppler US with a contrast agent--preliminary results.Radiology, 1998
- Clinical utility of color Doppler sonography in the differentiation of hepatocellular carcinoma from metastases and hemangiomaJournal of Ultrasound in Medicine, 1997
- Color Doppler ultrasound of liver lesions: Signal enhancement after intravenous injection of the ultrasound contrast agent Levovist®Journal of Clinical Ultrasound, 1996
- Characterization of focal hepatic lesions with duplex sonography: findings in 198 patients.American Journal of Roentgenology, 1995
- Effectiveness of galactose-based intravenous contrast medium on color doppler sonography of deeply located hepatocellular carcinomaUltrasound in Medicine & Biology, 1995
- Detection of hepatic masses in patients with carcinoma: comparative sensitivities of sonography, CT, and MR imaging.American Journal of Roentgenology, 1991